Report Detail

Pharma & Healthcare Global and United States Malaria Vaccines Market Insights, Forecast to 2026

  • RnM4203445
  • |
  • 14 September, 2020
  • |
  • Global
  • |
  • 126 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Malaria Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Malaria Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Malaria Vaccines Market Size Growth Rate by Type
    • 1.4.2 Pre-Erythrocytic Vaccine
    • 1.4.3 Erythrocytic Vaccine
    • 1.4.4 Multi-antigen Vaccine
  • 1.5 Market by Application
    • 1.5.1 Global Malaria Vaccines Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Community Centers
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Malaria Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global Malaria Vaccines Revenue 2015-2026
    • 2.1.2 Global Malaria Vaccines Sales 2015-2026
  • 2.2 Global Malaria Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Malaria Vaccines Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Malaria Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Malaria Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Malaria Vaccines Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Malaria Vaccines Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Malaria Vaccines Revenue Forecast by Region (2021-2026)

3 Global Malaria Vaccines Competitor Landscape by Players

  • 3.1 Global Top Malaria Vaccines Sales by Manufacturers
    • 3.1.1 Global Malaria Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Malaria Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Malaria Vaccines Manufacturers by Revenue
    • 3.2.1 Global Malaria Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Malaria Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Malaria Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Malaria Vaccines Revenue in 2019
    • 3.2.5 Global Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Malaria Vaccines Price by Manufacturers
  • 3.4 Global Malaria Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 Malaria Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Malaria Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Malaria Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Malaria Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global Malaria Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global Malaria Vaccines Revenue by Type (2015-2020)
    • 4.1.3 Malaria Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Malaria Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Malaria Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Malaria Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Malaria Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Malaria Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Malaria Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global Malaria Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global Malaria Vaccines Revenue by Application (2015-2020)
    • 5.1.3 Malaria Vaccines Price by Application (2015-2020)
  • 5.2 Malaria Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Malaria Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Malaria Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Malaria Vaccines Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Malaria Vaccines Market Size YoY Growth 2015-2026
    • 6.1.1 United States Malaria Vaccines Sales YoY Growth 2015-2026
    • 6.1.2 United States Malaria Vaccines Revenue YoY Growth 2015-2026
    • 6.1.3 United States Malaria Vaccines Market Share in Global Market 2015-2026
  • 6.2 United States Malaria Vaccines Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Malaria Vaccines Players by Sales (2015-2020)
    • 6.2.2 United States Top Malaria Vaccines Players by Revenue (2015-2020)
  • 6.3 United States Malaria Vaccines Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Malaria Vaccines Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Malaria Vaccines Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Malaria Vaccines Price by Type (2015-2020)
  • 6.4 United States Malaria Vaccines Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Malaria Vaccines Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Malaria Vaccines Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Malaria Vaccines Price Forecast by Type (2021-2026)
  • 6.5 United States Malaria Vaccines Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Malaria Vaccines Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Malaria Vaccines Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Malaria Vaccines Price by Application (2015-2020)
  • 6.6 United States Malaria Vaccines Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Malaria Vaccines Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Malaria Vaccines Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Malaria Vaccines Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Malaria Vaccines Market Size YoY Growth 2015-2026
  • 7.2 North America Malaria Vaccines Market Facts & Figures by Country
    • 7.2.1 North America Malaria Vaccines Sales by Country (2015-2020)
    • 7.2.2 North America Malaria Vaccines Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Malaria Vaccines Market Size YoY Growth 2015-2026
  • 8.2 Europe Malaria Vaccines Market Facts & Figures by Country
    • 8.2.1 Europe Malaria Vaccines Sales by Country
    • 8.2.2 Europe Malaria Vaccines Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Malaria Vaccines Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Malaria Vaccines Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Malaria Vaccines Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Malaria Vaccines Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Malaria Vaccines Market Size YoY Growth 2015-2026
  • 10.2 Latin America Malaria Vaccines Market Facts & Figures by Country
    • 10.2.1 Latin America Malaria Vaccines Sales by Country
    • 10.2.2 Latin America Malaria Vaccines Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Malaria Vaccines Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Malaria Vaccines Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Malaria Vaccines Sales by Country
    • 11.2.2 Middle East and Africa Malaria Vaccines Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 GlaxoSmithKline plc
    • 12.1.1 GlaxoSmithKline plc Corporation Information
    • 12.1.2 GlaxoSmithKline plc Description and Business Overview
    • 12.1.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 GlaxoSmithKline plc Malaria Vaccines Products Offered
    • 12.1.5 GlaxoSmithKline plc Recent Development
  • 12.2 Sanaria Inc
    • 12.2.1 Sanaria Inc Corporation Information
    • 12.2.2 Sanaria Inc Description and Business Overview
    • 12.2.3 Sanaria Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Sanaria Inc Malaria Vaccines Products Offered
    • 12.2.5 Sanaria Inc Recent Development
  • 12.3 Nobelpharma Co
    • 12.3.1 Nobelpharma Co Corporation Information
    • 12.3.2 Nobelpharma Co Description and Business Overview
    • 12.3.3 Nobelpharma Co Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Nobelpharma Co Malaria Vaccines Products Offered
    • 12.3.5 Nobelpharma Co Recent Development
  • 12.4 Sumaya Biotech
    • 12.4.1 Sumaya Biotech Corporation Information
    • 12.4.2 Sumaya Biotech Description and Business Overview
    • 12.4.3 Sumaya Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Sumaya Biotech Malaria Vaccines Products Offered
    • 12.4.5 Sumaya Biotech Recent Development
  • 12.5 GenVec
    • 12.5.1 GenVec Corporation Information
    • 12.5.2 GenVec Description and Business Overview
    • 12.5.3 GenVec Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 GenVec Malaria Vaccines Products Offered
    • 12.5.5 GenVec Recent Development
  • 12.11 GlaxoSmithKline plc
    • 12.11.1 GlaxoSmithKline plc Corporation Information
    • 12.11.2 GlaxoSmithKline plc Description and Business Overview
    • 12.11.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 GlaxoSmithKline plc Malaria Vaccines Products Offered
    • 12.11.5 GlaxoSmithKline plc Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Malaria Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Malaria Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Malaria Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Malaria Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Malaria Vaccines market is segmented into
    Pre-Erythrocytic Vaccine
    Erythrocytic Vaccine
    Multi-antigen Vaccine

    Segment by Application, the Malaria Vaccines market is segmented into
    Hospitals
    Clinics
    Community Centers

    Regional and Country-level Analysis
    The Malaria Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Malaria Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Malaria Vaccines Market Share Analysis
    Malaria Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Malaria Vaccines business, the date to enter into the Malaria Vaccines market, Malaria Vaccines product introduction, recent developments, etc.
    The major vendors covered:
    GlaxoSmithKline plc
    Sanaria Inc
    Nobelpharma Co
    Sumaya Biotech
    GenVec
    ...


    Summary:
    Get latest Market Research Reports on Malaria Vaccines. Industry analysis & Market Report on Malaria Vaccines is a syndicated market report, published as Global and United States Malaria Vaccines Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Malaria Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,060.47
    4,590.70
    6,120.93
    3,350.17
    5,025.26
    6,700.35
    411,508.50
    617,262.75
    823,017.00
    287,397.63
    431,096.45
    574,795.26
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report